Sleep-Disordered Breathing in Precapillary Pulmonary Hypertension: Is the Prevalence So High?

Zhenzhen Zheng,Riken Chen,Chunhe Li,Jianmin Lu,Haimin Liu,Cheng Hong,Nuofu Zhang

DOI: https://doi.org/10.1159/000518142

2021-01-01

Respiration

Abstract:SelectLearn moreSelectSubcription rates

respiratory system

What problem does this paper attempt to address?

Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?

Robert Thurnheer,Silvia Ulrich,Konrad E. Bloch

DOI: https://doi.org/10.1159/000452957

2016-11-25

Respiration

Abstract:Among patients with sleep apnea the reported prevalence of precapillary pulmonary hypertension (PH) has varied largely, depending on patient selection, disease definition, and associated conditions, in particular chronic pulmonary disease. However, in the absence of comorbidities, PH seems to be rare in patients with sleep apnea. Conversely, sleep-related breathing disorders have been commonly found in patients with PH and they have been associated with an impaired quality of life. Since sleep-related breathing disorders may affect the pulmonary circulation and vice versa, patients with sleep-related breathing disorders should be evaluated for risk factors, symptoms and clinical signs of PH and right ventricular heart failure and patients with PH should be evaluated for sleep apnea. Therapeutic options for patients with sleep apnea and PH may include supplemental oxygen, drugs and positive pressure ventilation. Both nocturnal oxygen administration and acetazolamide have been shown to improve sleep apnea in patients with PH. In addition, oxygen therapy also improved exercise performance. Further studies are needed to corroborate the efficacy of these and other treatments.

respiratory system
Considering Psychosocial Factors when Investigating Blood Pressure in Patients with Short Sleep Duration: A Propensity Score Matched Analysis

Ningjing Qian,Dandan Yang,Huajun Li,Siyin Ding,Xia Yu,Qingqiu Fan,Zhebin Yu,Shenfeng Ye,Hualiang Yu,Yaping Wang,Xiaohong Pan

DOI: https://doi.org/10.1155/2021/7028942

2021-01-01

International Journal of Hypertension

Abstract:Few studies have considered psychosocial characteristics when investigating the associations between sleep duration and blood pressure (BP). In this study, we took propensity score matching (PSM) to adjust for psychosocial characteristics when comparing BP between individuals with short sleep duration and those with normal sleep duration. A total of 429 participants were included. 72 participants with sleep duration ≤6 h and 65 participants with sleep duration >6 h were matched after PSM. We compared office BP, 24-hour BP, and prevalence of hypertension in the populations before and after PSM, respectively. In the unmatched population, participants with sleep duration ≤6 h were observed with higher office diastolic BP (DBP) and 24-h systolic BP (SBP)/DBP (all P<0.05). In the matched populations, the differences between the two groups (sleep duration ≤6 h vs. sleep duration >6 h) in office DBP (88.4 ± 10.9 vs. 82.5 ± 11.1 mm Hg; P=0.002), 24-h SBP (134.7 ± 12.0 vs. 129.3 ± 11.6 mm Hg; P=0.009), and 24-h DBP (83.4 ± 9.9 vs. 78.1 ± 10.1 mm Hg; P=0.002) become more significant. Participants with sleep duration ≤6 h only show higher prevalence of hypertension based on 24-h BP data, while analysis after PSM further revealed that these with sleep duration ≤6 h presented about 20% higher prevalence of elevated BP up to office diagnosed hypertension threshold. Therefore, psychosocial characteristics accompanied with short sleep duration should be fully valued in individuals at risks for elevated BP. This trial is registered with NCT03866226.
Sleep-related disorders in patients with precapillary pulmonary hypertension

Hsin-Yu Chao,Brendon J Yee,Chih-Hsin Hsu,Hsing-Mei Chen,Edmund M Lau

DOI: https://doi.org/10.1016/j.smrv.2024.101972

2024-07-03

Abstract:Precapillary pulmonary hypertension (PcPH) is associated with the development of sleep-related disorders and impairment of sleep quality. With growing recognition of the clinical relevance of sleep-related conditions in PcPH, this narrative review seeks to discuss the spectrum of disorders encountered in clinical practice, pathophysiological mechanisms linking PcPH with sleep-related disorders, and potential therapeutic considerations. Current evidence demonstrates a higher prevalence of impaired sleep quality, sleep-disordered breathing, sleep-related hypoxia, and restless leg syndrome in patients with PcPH. These sleep-related disorders could further lead to impairment of quality of life in a patient population with already a high symptom burden. Recent data suggest that sleep-related hypoxia is strongly linked to worse right ventricular function and higher risk of transplantation or death. However, limited studies have investigated the role of oxygen therapy or positive airway pressure therapy improving symptoms or outcomes. Abnormal iron homeostasis is highly prevalent in PcPH and may contribute to the development of restless legs syndrome/periodic limb movement of sleep. To improve sleep management in PcPH, we highlight future research agenda and advocate close collaboration between pulmonary hypertension specialists and sleep physicians.
Nocturnal Myocardial Ischemic Events and Sleep-Disordered Breathing in Patients with Coronary Artery Disease

Wenli,Bo Zhang,Shiwen,Hong Wang,Caiyi,Jiwen Lu,Peng,Ming Liu,Rui,Guihai Chen,) Xi'an,Ji,Yusheng,Xiujian Zhao

2004-01-01

Abstract:Objective To investigate the occurrence of nocturnal myocardial ischemia and its relationship with sleep-disordered breathing (apneas and oxygen desaturations) in patients with angina pectoris undergoing coronary angiography.Methods Eighty-two men and 14 women referred for consideration of coronary intervention were randomly selected. Observation by an overnight sleep monitor and Holter recording were performed to study sleep-disordered breathing (oxyhemoglobin desaturations≥4％ and apnea-hypopneas),heart rates, and ST-segment depressions (≥ 1mm, ≥1 min).Results Nocturnal ST-segment depressions occurred in 37 ％ of the patients. ST-segment depression within 2 min after an apnea-hypopnea or desaturation occurred in 17％ of the patients. This temporal association was seen in 21％ of the patients with nocturnal ST-segment depressions, more frequently in men (P＜0.05) and more frequently in those with severe disordered breathing (P＜0.05).Most of these ST-segment depressions were preceded by a series of breathing events: repeated apnea-hypopneas or desaturations or both in 73％ of the patients. Conclusions Episodes of nocturnal myocardial ischemia are common in patients with angina pectoris. A temporal relationship between sleep-disordered breathing and myocardial ischemia was present in some of our patients, and occurs more frequently in men and in those with severely disordered breathing. (J Geriatr Cardiol 2004;1(2):90-94.)
Sleep Quality and Its Predictors among Dyspnea, Fatigue and Exercise Capacity in Pulmonary Arterial Hypertension

Raziye Ceylan,Rengin Demir,Melih Zeren,Umit Yasar Sinan,Mehmet Serdar Kucukoglu

DOI: https://doi.org/10.6515/ACS.202409_40(5).20240712A

Abstract:Background: Poor sleep quality is an overlooked symptom in patients with pulmonary arterial hypertension (PAH), however it may significantly contribute to disease burden. Objectives: The aim of this study was to assess the sleep quality of patients with PAH and investigate its association with dyspnea, fatigue, and exercise capacity. Methods: Forty-five patients were included. Sleep quality of the patients was assessed by the Pittsburgh Sleep Quality Index (PSQI), dyspnea levels were assessed by the UCSD-Shortness of Breath Questionnaire (UCSD-SOBQ), Baseline Dyspnea Index (BDI), Modified Medical Research Council (MMRC) dyspnea scale and Modified Borg Dyspnea scale, fatigue levels were evaluated with the Fatigue Severity Scale and Borg Rating of Perceived Exertion, and functional exercise capacity was evaluated with the 6-minute walk test (6MWT). Results: Among the patients with PAH, 64% had poor sleep quality (PSQI > 5). PSQI score was significantly correlated with MMRC scale (r = -0.561), UCSD-SOBQ (r = 0.497), BDI (r = -0.468), and 6MWT (r = -0.412) (p < 0.05). There was no significant relationship between sleep quality and fatigue. A regression model including MMRC and 6MWT could explain 32% of variance in PSQI (p < 0.05), and MMRC score was an independent predictor for PSQI (p < 0.05). In addition, MMRC score had a greater influence on PSQI than 6MWT (β = 0.548 vs. 0.019). Conclusions: Poor sleep quality is common in patients with PAH and is associated with poor exercise capacity and dyspnea. Patients with severe dyspnea are particularly at higher risk of poor sleep quality. Consideration of sleep-related complaints and underlying mechanisms when planning symptomatic treatments for these patients may help provide better management for PAH.
Sleep‐disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary disease

Hui‐Ting Li,Ping Yuan,Rong Jiang,Qin‐Hua Zhao,Yuan‐Yuan Sun,Jian Zhang,Su‐Gang Gong,Jin‐Ling Li,Hong‐Ling Qiu,Wen‐Hui Wu,Ci‐Jun Luo,Jiang Xu,Lan Wang,Jin‐Ming Liu

DOI: https://doi.org/10.1111/imj.16359

2024-04-03

Internal Medicine Journal

Abstract:Background and Aims Sleep‐disordered breathing (SDB) and nocturnal hypoxemia were known to be present in patients with chronic thromboembolic pulmonary hypertension (CTEPH), but the difference between SDB and nocturnal hypoxemia in patients who have chronic thromboembolic pulmonary disease (CTEPD) with or without pulmonary hypertension (PH) at rest remains unknown. Methods Patients who had CTEPH (n = 80) or CTEPD without PH (n = 40) and who had undergone sleep studies from July 2020 to October 2022 at Shanghai Pulmonary Hospital were enrolled. Nocturnal mean SpO2 (Mean SpO2) <90% was defined as nocturnal hypoxemia, and the percentage of time with a saturation below 90% (T90%) exceeding 10% was used to evaluate the severity of nocturnal hypoxemia. Logistic and linear regression analyses were performed to investigate the difference and potential predictor of SDB or nocturnal hypoxemia between CTEPH and CTEPD without PH. Results SDB was similarly prevalent in CTEPH and CTEPD without PH (P = 0.104), both characterised by obstructive sleep apnoea (OSA). Twenty‐two patients with CTEPH were diagnosed with nocturnal hypoxemia, whereas only three were diagnosed with CTEPD without PH (P = 0.021). T90% was positively associated with mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance in patients with CTEPH and CTEPD without PH (P

medicine, general & internal
The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea

Lu Yan,Zhihui Zhao,Qing Zhao,Qi Jin,Yi Zhang,Xin Li,Anqi Duan,Qin Luo,Zhihong Liu

DOI: https://doi.org/10.1186/s12890-021-01755-5

IF: 3.1

2021-11-21

BMC Pulmonary Medicine

Abstract:Abstract Objective Obstructive sleep apnoea (OSA) is one cause of pulmonary hypertension (PH) and can also emerge along with PH. The clinical diagnosis and treatment of OSA in patients with PH are still controversial. The purpose of this clinical observation study was to observe and summarize the incidence and clinical characteristics of OSA in patients with PH and to explore possible predictors of PH combined with OSA. Methods Patients with PH diagnosed by right heart catheterization who underwent overnight cardiorespiratory monitoring from December 2018 to December 2020 were enrolled. OSA was defined as an apnoea–hypopnoea index of ≥ 5/h with ≥ 50% of apnoeic events being obstructive. Baseline clinical characteristics and parameters were collected to compare PH patients with and without OSA. Logistic regression analysis was run to determine the risk factors for OSA in PH patients. Results A total of 35 (25%) of 140 patients had OSA. OSA is relatively frequent in patients with PH, especially in patients with chronic thromboembolic pulmonary hypertension and patients with lung disease– or hypoxia-associated PH. The patients who had OSA were mostly male and had a higher age and a lower daytime arterial oxygen pressure. Logistic regression analysis found that older age, male sex, and lower daytime arterial blood oxygen pressure correlated with OSA in PH patients. Conclusion OSA is common in patients with PH. Lower daytime arterial oxygen pressure is a risk factor for OSA in older male patients with PH.

respiratory system
The comorbidity burden and disease phenotype in pre-capillary pulmonary hypertension: The contributing role of obstructive sleep apnea

Anqi Duan,Zhihua Huang,Meixi Hu,Zhihui Zhao,Qing Zhao,Qi Jin,Lu Yan,Yi Zhang,Xin Li,Chenhong An,Qin Luo,Zhihong Liu

DOI: https://doi.org/10.1016/j.sleep.2022.10.029

IF: 4.842

2022-11-03

Sleep Medicine

Abstract:Background Pre-capillary pulmonary hypertension (PH) with risk factors for left ventricular diastolic dysfunction, described as an atypical phenotype of "mixed" pre- and post-capillary PH, has become a research focus. However, the relationship between obstructive sleep apnea (OSA), a known risk factor for cardiometabolic conditions, and comorbidity burden and disease phenotype in PH remains unclear. Objective This study aimed to investigate the effect of the presence and severity of OSA on the left ventricular function, comorbidity burden and disease phenotype in pre-capillary PH patients. Methods and results We retrospectively examined 450 consecutive pre-capillary PH patients undergoing cardiorespiratory polygraphy and right heart catheterization between May 2020 to November 2021 at Fuwai Hospital. The prevalence of OSA was 34.2%, and the presence and severity of OSA in pre-capillary PH patients was associated with increased left heart mass index ( P < 0.001), pulmonary arterial wedge pressure ( P = 0.06) and H 2 FPEF score ( P < 0.001). After adjustment for confounding factors, the severity of OSA measured as apnea-hypopnea index (AHI) was an independent risk factor associated with obesity, systemic hypertension, diabetes mellitus and an atypical phenotype (OR: 1.054, P = 0.004) in pre-capillary PH. A dose-response relationship was also identified between sleep parameters (AHI, oxygen desaturation index, the percentage of sleep time with oxygen saturation<80%) and the number of key comorbidities. Patients with ≥3 comorbidities (atypical phenotype) were older, experienced negative alterations in left ventricular structure and function, and were at a higher risk of OSA. Conclusion OSA is relatively prevalent in pre-capillary PH patients, independently associated with the presence of a variety of comorbidities and the atypical phenotype of PH. These findings highlight the importance of OSA as a modifiable target for optimal treatment in PH with comorbidities.

clinical neurology
IMPACT OF PROLONGED NOCTURNAL HYPOXEMIA ON LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH PRE-CAPILLARY PULMONARY HYPERTENSION

Zhihua Huang,Zhihong Liu,Qin Luo,Zhihui Zhao,Qing Zhao,Yi Zhang,Xin Li,Anqi Duan,Meixi Hu

DOI: https://doi.org/10.1097/01.hjh.0000941944.86293.ea

IF: 4.9

2023-06-01

Journal of Hypertension

Abstract:Obstructive sleep apnea (OSA) and/or nocturnal hypoxemia is prevalent in patients with pulmonary hypertension (PH). However, the pathophysiological determinants of adverse outcomes remain ambiguous. We aimed to investigate the prognostic significance of various sleep parameters for long-term prognosis in patients with pre-capillary PH. Consecutive patients diagnosed with precapillary pulmonary hypertension (PH) by right heart catheterization who underwent overnight cardiorespiratory polygraphy for the assessment of OSA were enrolled. Time-to-event analysis was performed investigating cardiorespiratory indices (apnea-hypopnea index [AHI] and percentage total recording time <90% [T90]) and clinical worsening using the log-rank test and multivariable Cox proportional hazard models adjusted for multiple confounders. Of 440 eligible Chinese patients with PH, 134 (30.5%) had OSA and 147 (33.4%) had nocturnal hypoxemia (T90 greater than 10%). Over a median follow-up of 12.1 months, 72 (16.4%) patients experienced clinical worsening. AHI did not predict a higher risk of incident CW (hazard ratio [HR]: 0.98, 95% confidence interval [CI]: 0.932-1.001, P = 0.225), whereas T90 was associated with an increased risk of CW (HR: 1.01, 95% CI 1.00-1.01, P = 0.018). The likelihood of CW increased by 8% per 10-unit increase in T90 (HR: 1.08, 95% CI 1.020-1.14, P = 0.018). Patients with nocturnal hypoxemia carried an HR of 1.89 for CW events (HR: 1.89, 95% CI 1.19-3.00, P = 0.007) and these associations persisted after covariates adjustments. Clinical worsening-free survival probability over two-year follow-up periods for patients with nocturnal normoxemia and hypoxemia were 87% and 76.9%, respectively (Log-rank P = 0.006), while the trend towards a non-statistical significance of patients with and without OSA. The association of nocturnal hypoxemia reflected by T90 and CW remained robust across different subgroups and did not potentially interact with potential effect modifiers including age, gender, BMI, and pulmonary hemodynamic parameters (P for interaction >0.05). In patients with precapillary PH, nocturnal hypoxemia defined by T90 was a robust risk predictor of long-term clinical worsening. Investigation of nocturnal hypoxemic burden in PH may aid in the early risk-stratification in patients with precapillary PH.

peripheral vascular disease
Prevalence, characteristics, and respiratory arousal threshold of positional obstructive sleep apnea in China: a large scale study from Shanghai Sleep Health Study cohort

Weijun Huang,Xiaoting Wang,Chong Xu,Huajun Xu,Huaming Zhu,Suru Liu,Jianyin Zou,Jian Guan,Hongliang Yi,Shankai Yin

DOI: https://doi.org/10.1186/s12931-022-02141-3

IF: 5.8

2022-09-12

Respiratory Research

Abstract:To evaluate the prevalence, characteristics, and respiratory arousal threshold (ArTH) of Chinese patients with positional obstructive sleep apnea (POSA) according to the Cartwright Classification (CC) and Amsterdam Positional Obstructive Sleep Apnea Classification (APOC).

respiratory system
Pulmonary hypertension in patients affected by sleep-related breathing disorders: up to date from the literature

Elvia Battaglia,Elena Compalati,Luca Mapelli,Agata Lax,Paola Pierucci,Paolo Solidoro,Paolo Banfi

DOI: https://doi.org/10.23736/S0026-4806.24.09112-2

2024-07-17

Abstract:Sleep-related breathing disorders (SBD) are conditions of abnormal and difficult respiration during sleep, including chronic snoring, obstructive sleep apnea (OSA), central sleep apnea (CSA), sleep-related hypoventilation disorders and sleep-related hypoxemia. Some of them have a limited impact on health, but others (e.g., OSA) can have serious consequences, because of their dangerous effects on sleep and the hematic balance of oxygen and carbon dioxide. According to several population-based studies, prevalence of OSA is relatively high, approximately 3-7% for adult males and 2-5% for adult females in the general population. However, methodological differences and difficulties in characterizing this syndrome yielded to variability in estimates. Moreover, it is estimated that only about 40% of patients with OSA are diagnosed, which can lead to underestimation of disease prevalence. OSA is directly correlated with age and male sex and to risk factors such as obesity. Several studies found that OSA is associated with an increased risk of diabetes, some cancer types, cardiovascular and cerebrovascular diseases, such as hypertension, coronary artery disease and stroke. Pulmonary hypertension (PH), a noted cardiovascular disease, is significantly associated with sleep-related breathing disorders and lot of scientific studies published in the literature demonstrated a strong link between these conditions and the development of pulmonary hypertension PH. PH is relatively less common than sleep-related breathing disorders. The purpose of this systematic review is to analyze both the current knowledge around the consequences that SBD may have on pulmonary hemodynamics and the effects resulting from pharmacological and non-pharmacological treatments of SDB on PH.
Primary Aldosteronism and Sleep Apnea Syndrome

Fu-chun ZHANG,Zhi-tao YAN,Jing-jing YANG,Nan-fang LI

DOI: https://doi.org/10.13241/j.cnki.pmb.2010.04.057

2010-01-01

Abstract:Recently, as the improvement of screening technology ,there is the high prevence of primary hyperaldosteronism .Besides, it is presented that It is an higher prevence of PA with resistant hypertension than essential hypertension ,which is from less than 1% to 5%-15% . PA was more prevalent in subjects at high risk compared to subjects at low risk symptom of OSA .So there would be some relationships between the PA and OSA ,such as physiopathologic and both leading to resistant hypertension、sever heart and kidney complication. Aldosterone which is bring from PA or hypoxia and high carbonation of OSA can bring about resistant hypertension 、sever heart and kidney complication. However ,the relationship between PA and OSA are not clear ,we should research deeply.
Association Between Preserved Ratio Impaired Spirometry and Sleep Apnea in a Chinese Community.

Cheng Zhang,Shanshan Wei,Yunxia Wang,Kunyao Yu,Zhe Jin,Meng Zhang,Xiaoyu Ma,Chunbo Zhang,Qi Zhang,Kunyan Sun,Peining Zhou,Yijue Zhong,Jing Ma,Jiping Liao,Guangfa Wang

DOI: https://doi.org/10.1080/03007995.2023.2182531

2023-01-01

Current Medical Research and Opinion

Abstract:Abstract Objective This study investigated the association between obstructive sleep apnea (OSA) and preserved ratio impaired spirometry (PRISm) in a community population. Methods Baseline data from a prospective cohort study, the Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV1 for COPD (PIFCOPD), were used for cross-sectional analysis. Participants aged 40–75 years were recruited from the community and their demographic information and medical history were collected. The STOP-Bang questionnaire (SBQ) was used to assess the risk of OSA. Pulmonary function tests were performed using a portable spirometer (COPD-6) and forced expiratory volume in 1 s (FEV1) and 6 s (FEV6) were measured. Routine blood, biochemical, high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 tests were also performed. The pH of the exhaled breath condensate was determined. Results A total of 1183 participants were enrolled, of which 221 with PRISm and 962 with normal lung function. The neck circumference, waist-to-hip ratio, hs-CRP concentration, proportion of males, cigarette exposure, number of current smoker, high risk of OSA, and prevalence of nasal and ocular allergy symptoms were significantly higher in the PRISm group than in the non-PRISm group (p < .05). Logistic regression showed that the risk of OSA (odds ratio, 1.883; 95% confidence interval, 1.245–2.848), waist-to-hip ratio, current smoking, and prevalence of nasal allergy symptoms were independently associated with PRISm after correcting for age and sex. Conclusion These findings showed that OSA prevalence is independently associated with PRISm prevalence. Further studies should confirm the relationship between systemic inflammation in OSA, localized inflammation of the airways, and impaired lung function.
Prevalence and associated factors of obstructive sleep apnea in refractory hypertension

Bernardo Chedier,Christian N Roderjan,Aline H Cavalcanti,Fabio de Souza,Elizabeth S Muxfeldt

DOI: https://doi.org/10.1097/HJH.0000000000003144

2022-07-01

Abstract:Background: Refractory hypertension (RfHT) and obstructive sleep apnea (OSA) share common pathophysiological mechanisms and probably are intrinsically associated, but their prevalence, clinical profile, and polysomnography (PSG) pattern remain misunderstood. Objective: To describe OSA prevalence and PSG pattern of patients with RfHT in a large cohort of resistant hypertension (RHT). Methods: This is a cross-sectional study involving 418 RHT patients (30.9% male; mean age of 62.5 ± 9.9 years) who were submitted to full-night PSG. RfHT was defined as uncontrolled ambulatory blood pressure monitoring using five or more antihypertensive drugs, including spironolactone. Bivariate analysis compared RHT and RfHT and multivariate analysis was performed to assess the independent correlates of OSA. Results: A total of 90 patients (21.5%) were diagnosed with RfHT (26.7% male; mean age of 58.5 ± 8.3 years). In comparison with resistant ones, RfHT patients were younger, with higher smoking and previous cardiovascular diseases prevalence, especially stroke. There was no difference regarding anthropometric measures. OSA prevalence (80.0 vs. 82.9%) and moderate/severe OSA (51.1 vs. 57.0%) were similar in both groups as well as apnea-hypopnea index. In its turn, refractory hypertensive patients presented better sleep efficiency (78 vs. 71%), with higher total sleep time (315 vs. 281 min) and lower sleep latency (11 vs. 17 min). There was no difference regarding rapid eye movement sleep, oxygen saturation, microarousals index, and periodic limb movement. Conclusion: In this large RHT cohort, resistant and refractory hypertensive patients have similar OSA prevalence, although refractory ones, which by definition use spironolactone, are younger and apparently have a better sleep pattern.
Sex-specific differences in sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease

Hui-Ting Li,Ping Yuan,Qin-Hua Zhao,Su-Gang Gong,Rong Jiang,Jin-Ling Li,Hong-Ting Liu,Hong-Ling Qiu,Wen-Hui Wu,Ci-Jun Luo,Jing He,Lan Wang,Jin-Ming Liu

DOI: https://doi.org/10.3389/fcvm.2022.966973

IF: 3.6

2022-10-18

Frontiers in Cardiovascular Medicine

Abstract:Objective: Although chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease (CTEPD) are known to be accompanied by symptoms associated with sleep-disordered breathing (SDB) and nocturnal hypoxemia, the sex-specific differences of SDB and nocturnal hypoxemia in patients with CTEPH and CTEPD remain unknown. Methods: Between July 2020 and August 2022, data were retrieved from 57 males and 63 female patients with CTEPH and CTEPD who underwent sleep study at Shanghai Pulmonary Hospital. Nocturnal mean SpO 2 (mean SpO 2 ) < 90% was defined as nocturnal hypoxemia. Logistic and linear regression analysis was performed to assess the predictive value of sleep study indices to hemodynamic parameters. Receiver operating characteristic (ROC) curve was applied to analyze the specific parameters to predict the risk of CTEPH. Results: SDB was similarly present in males and females, and both sexes predominantly had obstructive sleep apnea (OSA); more women were diagnosed with nocturnal hypoxemia (32 vs. 7%, p = 0.002). SaO 2 was negatively associated with mean pulmonary arterial pressure (mPAP) in men ( p < 0.001), whereas the ratio of nocturnal SpO 2 < 90% of the total monitoring time (T90%) was positively correlated with mPAP. Mean SpO 2 was an independent predictor for pulmonary vascular resistance and cardiac output in women ( p = 0.001, p < 0.001, p = 0.001, respectively). T90%, SaO 2 , and minimal SpO 2 were combined to develop a new composite parameter: hypoxemia scoring index (HSI). ROC curve analysis indicated that HSI levels of 0.55 could discriminate CTEPH from CTEPD with a sensitivity of 92.3% and specificity of 87.5% in female patients (an area under the curve, 0.937; 95% CI: 0.879–0.995, p < 0.001). Conclusion: Sex-specific nocturnal hypoxemia was present in patients with CTEPH or CTEPD. In female patients, the HSI showed high capacity for predicting the risk of CTEPH. Clinical trials registration: Registry: chictr.org.cn; Identifier: ChiCTR-DDD-16009406.

cardiac & cardiovascular systems
Association Between Exposure to Air Pollutants and Sleep Parameters in Chronic Obstructive Pulmonary Disease Patients with or Without Obstructive Sleep Apnea

Junyi Wang,Wanlu Sun,Wanzhou Wang,Wenlou Zhang,Ying Wang,Yongwei Huang,Jianli Wang,Liqiang Zhang,Yahong Chen,Xinbiao Guo,Furong Deng,Peifang Wei

DOI: https://doi.org/10.1097/cm9.0000000000002281

IF: 6.133

2022-01-01

Chinese Medical Journal

Abstract:To the Editor: Air pollution is a rapidly developing environmental problem worldwide. A large number of studies have indicated that ambient air pollutants have effects on mortality and morbidity of respiratory diseases. Remarkably, paramount attention should be paid to the impact on respiratory diseases associated with air pollution from a public health standpoint. Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease characterized by partially irreversible chronic airflow limitation that may lead to disability and impaired quality of life. The most recent national survey in China reports that the overall prevalence of COPD patients aged ≥40 years has reached 13.7% in 2012 to 2015. Obstructive sleep apnea (OSA), one of the common complications of COPD, is characterized by repetitive episodes of partial or complete upper airway obstruction during sleep, leading to sleep apneahypopnea, hypoxemia, and sleep fragmentation.
Determinants of sleep disturbances in patients with pulmonary arterial hypertension

K Sarzynska,B J P Beata Jankowska-Polanska

DOI: https://doi.org/10.1093/eurjcn/zvae098.062

2024-07-01

European Journal of Cardiovascular Nursing

Abstract:Abstract Introduction Pulmonary arterial hypertension (PAH) is a rare, chronic disease that leads to the development of a range of cardiopulmonary and cardiovascular symptoms. Studies indicate that sleep problems may contribute to the deterioration of function in patients with PAH. Identifying factors that are related to the occurrence of sleep disorders can help identify them, and will also allow you to take steps to minimize the risk of insomnia. Purpose The aim of this study was to determine the determinants affecting the incidence of sleep disorders among patients with pulmonary arterial hypertension. Material and methods The study included 89 patients with a diagnosis of pulmonary arterial hypertension (PAH) who are chronically treated and participate in the state program for Therapeutic Treatment of Pulmonary Arterial Hypertension by the National Health Service. The study used standardized tools: a self-administered survey questionnaire, as well as the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Results Patients had a mean PSQI score of M=8.7 (SD=4.64), indicating low sleep quality. Factors that had a significant impact on sleep disturbance were: old age (r=0.373), chest pain (r=0.307), weakness (r=0.296), fatigue (r=0.316), shortness of breath (r=0.242), MWT score 6 (r= -0.237), NT-proBNP (r=0, 517), social support (r=0.237), staying in a relationship (r= -0.21), arrhythmia (r=0.211), number of hospitalizations (r=0.33), male gender (r=0.257), WHO FC class (r=0.503). Conclusions In the study group of patients with PAH, sleep disorders are present in the majority. The progression of clinical symptoms and selected sociodemographic data significantly correlate with the occurrence of insomnia.

nursing,cardiac & cardiovascular systems
[Respiration control dysfunction and the relationship to sleep-disordered breathing in patients with chronic obstructive pulmonary disease].

Zhong-Ming He,Xiao-Chuan Cui,Jing Li,Xiao-Song Dong,Yun-Hui Lü,Min Zhou,Xu Han,Pei An,Li Wang,Rong-Bao Zhang,Quan-Ying He,Fang Han

DOI: https://doi.org/10.3760/j.issn:1001-0939.2007.09.010

2007-01-01

Abstract:OBJECTIVE:To analyze the polysomnographic (PSG) features of sleep apnea hypopnea syndrome (SAHS) in patients with chronic obstructive pulmonary disease (COPD), and to define the association between SAHS and respiratory control disorder. METHODS:Three hundred patients with stable COPD were screened for SAHS using questionnaire, Epworth sleep scale (ESS) and home pulse oximeter testing. Those with ESS > or = 10 or oxygen desaturation over 3% more than 5 times per hour sleep were under further PSG testing. The PSG features were compared between COPD patients with apnea hypopnea index (AHI) > 10 and 118 SAHS patients with normal lung function. The two groups were matched for age, body mass index (BMI) and AHI. Among them 22 with COPD and AHI > or = 10 were tested for the chemo-responsiveness to isocapnic hypoxia and hypercapnia. RESULTS:Among the 300 patients with stable COPD, 79 had AHI over 10, meeting the diagnostic criteria of overlap syndrome (OS). Analysis of the polysomnography found that 32 cases (40%) with OS had more hypoventilation lasting over 1 min during sleep. Compared to patients with SAHS only, OS patients had higher percentage of hypopnea index over AHI [(69 +/- 30)% vs (52 +/- 31)%] and a higher percentage of total hypopnea time over total time of sleep apnea and hypopnea [(15 +/- 12)% vs (12 +/- 10)%]. OS patients also had lower hypoxic [(-0.11 +/- 0.05) vs (-0.35 +/- 0.24) L.min(-1).%(-1)] and hypercapnic responses [(1.1 +/- 0.8) vs (1.6 +/- 0.8) L.min(-1).mm Hg(-1) (1 mm Hg = 0.133 kPa)]. CONCLUSION:Patients with both COPD and SAHS had more episodes of hypopnea and hypoventilation during sleep, and had depressed chemo-responsiveness to hypoxia during wakefulness.
Impact of Obstructive Sleep Apnea on Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease

Wan-Lu Sun,Jian-Li Wang,Guo-Hua Jia,Wen-Jun Mi,Yi-Xuan Liao,Yong-Wei Huang,Zheng Hu,Li-Qiang Zhang,Ya-Hong Chen

DOI: https://doi.org/10.1097/cm9.0000000000000247

2019-01-01

Abstract:Background: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the effects of OSA on PH in patients with COPD and the associated factors. Methods: Consecutive patients with stable COPD were recruited for an observational cross-sectional study from September 2016 to May 2018 at Peking University Third Hospital. in total, 106 patients with COPD were enrolled and performed home portable monitoring and echocardiography. OSA was defined by an apnea hypopnea index (AHI) >= 10 events/h. Based on OSA absence or presence, patients were divided into the COPD with OSA and COPD without OSA groups. Factors affecting pulmonary artery pressure (PAP) and PH were identified using univariate analysis and logistic regression models. Results: In the 106 patients with COPD, the mean age was 69.52 years, 91.5% were men, and the mean forced expiratory volume in 1 s (FEV1) percentage of predicted was 56.15%. Fifty-six (52.8%) patients with COPD were diagnosed with OSA, and 24 (22.6%) patients with COPD were diagnosed as PH. Compared with COPD without OSA group, the median PAP in COPD with severe OSA group increased by 5 mmHg (36.00 [26.00-50.00] mmHg vs. 31.00 [24.00-34.00] mmHg, P = 0.036). COPD with percent of night-time spent with oxygen saturation below 90% (T90) > 10% group had higher PAP than COPD with T90 <= 1% group (36.00 29.00-50.00)] mmHg vs. 29.00 [25.50-34.00] mmHg, F = 7.889, P = 0.007). Univariate analysis revealed age, FEV1% predicted, T90, and Charlson index had statistically significant effects on PH. Multiple regression analysis showed a significant and independent effect of both FEV1% predicted (odds ratio [OR] = 3.46; 95% confidence interval [CI]: 1.15-10.46; P = 0.028) and AHI (OR = 3.20; 95% CI: 1.09-19.35; P = 0.034) on PH. Conclusions: Patients with COPD with OSA are more susceptible to PH, which is associated with declining lung function and increased severity of OSA. Thus, nocturnal hypoxemia and OSA in elderly patients with COPD should he identified and treated.
Sleep behaviour and cardiorespiratory fitness in patients after percutaneous coronary intervention during cardiac rehabilitation: protocol for a longitudinal study

Lan Huang,Jie Zhou,Husheng Li,Yiyan Wang,Xubo Wu,Jing Wu

DOI: https://doi.org/10.1136/bmjopen-2021-057117

IF: 3.006

2022-06-14

BMJ Open

Abstract:Introduction Most patients with coronary heart disease experience sleep disturbances and low cardiorespiratory fitness (CRF), but their relationship during cardiac rehabilitation (CR) is still unclear. This article details a protocol for the study of sleep trajectory in patients with coronary heart disease during CR and the relationship between sleep and CRF. A better understanding of the relationship between sleep and CRF on patient outcomes can improve sleep management strategies. Methods and analysis This is a longitudinal study with a recruitment target of 101 patients after percutaneous cardiac intervention from the Seventh People's Hospital of Shanghai, China. Data collection will include demographic characteristics, medical history, physical examination, blood sampling, echocardiography and the results of cardiopulmonary exercise tests. The information provided by a 6-min walk test will be used to supplement the CPET. The Pittsburgh Sleep Quality Index will be used to understand the sleep conditions of the participants in the past month. The Patient Health Questionnaire and General Anxiety Disorder Scale will be used to assess depression and anxiety, respectively. All participants will be required to wear an actigraphy on their wrists for 72 hours to monitor objective sleep conditions. This information will be collected four times within 6 months of CR, and patients will be followed up for 1 year. The growth mixture model will be used to analyse the longitudinal sleep data. The generalised estimating equation will be used to examine the associations between sleep and CRF during CR. Ethics and dissemination Ethical approval for this observational longitudinal study was granted by the Shanghai Seventh People's Hospital Ethics Committee on 23 April 2021 (2021-7 th -HIRB-012). Study results will be disseminated in peer-reviewed journal articles.

medicine, general & internal

Sleep-Disordered Breathing in Precapillary Pulmonary Hypertension: Is the Prevalence So High?

Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?

Considering Psychosocial Factors when Investigating Blood Pressure in Patients with Short Sleep Duration: A Propensity Score Matched Analysis

Sleep-related disorders in patients with precapillary pulmonary hypertension

Nocturnal Myocardial Ischemic Events and Sleep-Disordered Breathing in Patients with Coronary Artery Disease

Sleep Quality and Its Predictors among Dyspnea, Fatigue and Exercise Capacity in Pulmonary Arterial Hypertension

Sleep‐disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary disease

The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea

The comorbidity burden and disease phenotype in pre-capillary pulmonary hypertension: The contributing role of obstructive sleep apnea

IMPACT OF PROLONGED NOCTURNAL HYPOXEMIA ON LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH PRE-CAPILLARY PULMONARY HYPERTENSION

Prevalence, characteristics, and respiratory arousal threshold of positional obstructive sleep apnea in China: a large scale study from Shanghai Sleep Health Study cohort

Pulmonary hypertension in patients affected by sleep-related breathing disorders: up to date from the literature

Primary Aldosteronism and Sleep Apnea Syndrome

Association Between Preserved Ratio Impaired Spirometry and Sleep Apnea in a Chinese Community.

Prevalence and associated factors of obstructive sleep apnea in refractory hypertension

Sex-specific differences in sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease

Association Between Exposure to Air Pollutants and Sleep Parameters in Chronic Obstructive Pulmonary Disease Patients with or Without Obstructive Sleep Apnea

Determinants of sleep disturbances in patients with pulmonary arterial hypertension

[Respiration control dysfunction and the relationship to sleep-disordered breathing in patients with chronic obstructive pulmonary disease].

Impact of Obstructive Sleep Apnea on Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease

Sleep behaviour and cardiorespiratory fitness in patients after percutaneous coronary intervention during cardiac rehabilitation: protocol for a longitudinal study